However in the study by Eagan et al. OPG levels were higher in COPD patients with comorbid heart disease, including both heart failure and coronary heart disease [18], linking circulating systemic OPG levels to heart disease in patients with COPD. This evidence concerns the gene TNFRSF11B and coronary artery disorder.